Regulation of Posttranscriptional Modification as a Possible Therapeutic Approach for Retinal Neuroprotection

<table><i>Impairment of visual function and the protective effect of ARB in diabetic mice.</i> OPs in ERG from diabetic or nondiabetic mice. Amplitude and implicit time of OPs are impaired in the diabetic mice, but these changes were avoided by administrating ARB (Telmisartan). ERG: electroretinogram; Ops: oscillatory potentials; ARB: Angiotensin II type 1 receptor blocker.</table>

Journal of Ophthalmology

fig4

Figure 4

Figure 4: Regulation of Posttranscriptional Modification as a Possible Therapeutic Approach for Retinal Neuroprotection 